Biomarker Discovery Workflows News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Crown Bioscience
Monday, January 11, 2021 10:00AM IST (4:30AM GMT)
 
San Diego, United States:
 
Crown Bioscience, a JSR Life Sciences company, today announced the expansion of their state-of-the-art NGS capabilities, together with the launch of proprietary NGS panel services, providing increased opportunities for pharmaceutical partners to better understand drug mechanisms of action (MOA) and to develop predictive biomarkers for their investigational drug candidates.
 
(Graphic: Business Wire)
The newly built, comprehensive suite of NGS capabilities provides clients with a streamlined multi-omics workflow of high-quality services, enabling full genomic understanding, including global gene expression, mutations, and genomic structures. This is a significant addition to CrownBio’s current preclinical and translational services, allowing clients greater insight into disease mechanisms ....

San Diego , United States , Sheng Guo , Bionano Saphyr , Crown Bioscience , Henry Li , Company Center , Life Sciences , Crown Bioscience Inc , Business Wire , Translational Science , Genome Imaging , Media Contact , Jsr Life Sciences , Next Generation Sequencing , Biomarker Discovery Workflows , Drug Mechanisms , High Quality Services , Whole Genome Sequencing , Pac Bio , Variant Analysis , Cancer Treatments , Ngs Platforms , சான் டியாகோ , ஒன்றுபட்டது மாநிலங்களில் , ஷெங் கூவோ ,